Skip to main content

Table 1 Semi-structured interview guide

From: Qualitative assessment of the national initiative to implement antimicrobial stewardship centres in French administrative regions

Position and role in the CRAtb

What position do you hold in your CRAtb? How did you get to the position you hold today?

Implementation of the CRAtb

• Who were the actors involved in the prevention of antibiotic resistance before the establishment of the CRAtb in your region?

• When the CRAtb was established, how did you work with other regional actors involved in the prevention of antibiotic resistance? Please give examples.

• When the CRAtb was established, how did you work with other regional actors involved in the prevention of antibiotic resistance? Please give examples.

• What were the biggest obstacles to the establishment of the CRAtb?

• What positive changes have occurred with the establishment of the CRAtb in your region?

Role of the CRAtb in the regional coordination of antibiotic resistance prevention

• What are the activities of your CRAtb for the regional coordination of the prevention of antibiotic resistance?

• In your opinion, which of your activities are most critical to the prevention of antibiotic resistance?

• What are the greatest strengths of your CRAtb in preventing antibiotic resistance in your region?

• What are your CRAtb’s weaknesses in preventing antibiotic resistance in your region? Please give examples. How could these weaknesses be improved?

• What are the main actions to come in the next few months? Please specify.

Interactions with other regional antibiotic resistance prevention stakeholders

• In your region, how does the CRAtb work with the various actors in the prevention of antibiotic resistance? Please give examples.

• How does the CRAtb communicate with other actors involved in antibiotic resistance prevention? How is data shared?

• How would you describe the relationship between your CRAtb and other stakeholders involved in antibiotic resistance prevention? How could they be improved? Are there future collaborations to come?

• If there are no interactions with some of the actors in the prevention of antibiotic resistance, can you explain why? Can you comment on possible future collaborations? How could this be approached?

Final question

Is there anything we haven’t talked about that you think is important to address?

  1. Abbreviations: CRAtb, regional antimicrobial stewardship coordination centres